
{
  "drug_name": "Talicia",
  "tradename": "Talicia",
  "usage_and_dosing": {
    "description": "Three drug combination of omeprazole magnesium + amoxicillin + rifabutin for treatment of Helicobacter pylori infection in adults.",
    "capsule_contents": {
      "omeprazole": "10 mg",
      "amoxicillin": "250 mg",
      "rifabutin": "12.5 mg"
    },
    "adult_dose": {
      "dose": "4 capsules q8h with food x14 days",
      "instructions": "Swallow whole. Do not crush or chew. Do not take with alcohol."
    },
    "pediatric_dose": [
      {
        "age": ">28 Days",
        "dose": "Safety and efficacy not established"
      }
    ]
  },
  "renal_adjustment": {
    "half_life_normal_function": {
      "omeprazole": "1 hr",
      "amoxicillin": "1.4 hrs",
      "rifabutin": "34 hrs"
    },
    "half_life_esrd": {
      "amoxicillin": "5-20 hrs",
      "rifabutin": "Unchanged"
    },
    "dose_renal_function_normal": "4 caps q8h x14 days",
    "crcl_or_egfr": {
      "crcl_>30": "No dosage adjustment",
      "crcl_<30": "Not recommended"
    },
    "hemodialysis": "No data",
    "capd": "No data",
    "crrt": "No data",
    "sled": "No data"
  },
  "hepatic_adjustment": {
    "mild_impairment": "Avoid use",
    "moderate_impairment": "Avoid use",
    "severe_impairment": "Avoid use"
  },
  "adverse_effects": {
    "warnings": [
      "C. difficile-associated diarrhea (CDAD)",
      "Reduced efficacy of hormonal contraceptives",
      "Acute tubulointerstitial nephritis",
      "Cutaneous and systemic lupus erythematosus",
      "Rash in patients with mononucleosis",
      "Uveitis",
      "Interactions with diagnostic evaluations for neuroendocrine tumors"
    ],
    "adverse_reactions": [
      "GI (nausea/vomiting/diarrhea)",
      "Headache",
      "Abdominal pain",
      "Chromaturia",
      "Hypersensitivity reactions",
      "Dyspepsia",
      "Oropharyngeal pain",
      "Vulvovaginal candidiasis"
    ]
  },
  "pregnancy_risk": {
    "fda_risk_category": "Not recommended",
    "use_during_lactation": "Safety not established, avoid use"
  },
  "antimicrobial_spectrum": {
    "preferred": [
      "Helicobacter pylori"
    ],
    "alternative": []
  },
  "pharmacology": {
    "pk_pd_index": {
      "omeprazole": "no data",
      "amoxicillin": "T>MIC",
      "rifabutin": "24-hr AUC/MIC"
    },
    "pharmaceutical_preparations": "Cap (omeprazole 10 mg, amoxicillin 250 mg, rifabutin 12.5 mg)",
    "food_rec_po_drugs": "Cap + food",
    "oral_absorption": {
      "omeprazole": "no data",
      "amoxicillin": "no data",
      "rifabutin": "no data"
    },
    "tmax": {
      "omeprazole": "1.25 hrs",
      "amoxicillin": "2 hrs",
      "rifabutin": "3 hrs"
    },
    "peak_serum_conc": {
      "omeprazole": "1.28 (40 mg q8h, SS)",
      "amoxicillin": "15.9 (1 gm q8h, SS)",
      "rifabutin": "0.088 (50 mg q8h, SS)"
    },
    "peak_urine_conc": "No data",
    "protein_binding": {
      "omeprazole": "95%",
      "amoxicillin": "20%",
      "rifabutin": "85%"
    },
    "volume_of_distribution": {
      "omeprazole": "no data",
      "amoxicillin": "0.36 L/kg",
      "rifabutin": "9.3 L/kg (Vss)"
    },
    "avg_serum_t1_2": {
      "omeprazole": "1 hr",
      "amoxicillin": "1.4 hrs",
      "rifabutin": "34 hrs"
    },
    "elimination": {
      "omeprazole": "metabolized",
      "amoxicillin": "renal",
      "rifabutin": "metabolism, renal"
    },
    "bile_penetration": {
      "omeprazole": "no data",
      "amoxicillin": "100-3000%",
      "rifabutin": "300-500%"
    },
    "csf_blood": {
      "omeprazole": "no data",
      "amoxicillin": "13-14%",
      "rifabutin": "30-70%"
    },
    "therapeutic_levels_in_csf": {
      "omeprazole": "no data",
      "amoxicillin": "yes",
      "rifabutin": "no data"
    },
    "auc": {
      "omeprazole": "7.16 (40 mg q8h, 0-24h)",
      "amoxicillin": "145.8 (1 gm q8h, 0-24h)",
      "rifabutin": "1.32 (50 mg q8h, 0-24h)"
    }
  },
  "enzyme_transporter_mediated_interactions": {
    "cyp450s_that_drug_is_a_substrate_for": {
      "omeprazole": "CYP2C19, CYP3A4",
      "rifabutin": "CYP3A4"
    },
    "transporters_that_drug_is_a_substrate_for": {
      "amoxicillin": "OAT1, OAT3"
    },
    "cyp450s_inhibited_by_drug": {
      "omeprazole": "CYP2C19"
    },
    "cyp450s_induced_by_drug": {
      "rifabutin": "CYP3A4"
    }
  },
  "major_drug_interactions": [
    {
      "drug": "Allopurinol",
      "effect": "↑ frequency of rash",
      "suggestion": "Monitor, avoid if possible"
    },
    {
      "drug": "Cilostazol",
      "effect": "↑ cilostazol",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Citalopram",
      "effect": "↑ citalopram",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Clopidogrel",
      "effect": "↑ clopidogrel",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Dasatinib",
      "effect": "Altered absorption of dasatinib",
      "suggestion": "See PI of dasatinib"
    },
    {
      "drug": "Diazepam",
      "effect": "↑ diazepam",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Digoxin",
      "effect": "↑ digoxin",
      "suggestion": "Monitor, adjust dosage"
    },
    {
      "drug": "Erlotinib",
      "effect": "Altered absorption of erlotinib",
      "suggestion": "See PI of erlotinib"
    },
    {
      "drug": "Fluconazole",
      "effect": "↑ omeprazole, ↑ rifabutin",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Iron salts",
      "effect": "Altered absorption of iron",
      "suggestion": "See PI of iron salt"
    },
    {
      "drug": "Itraconazole",
      "effect": "↑ omeprazole, ↑ rifabutin",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Methotrexate",
      "effect": "↑ methotrexate",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Mycophenolate mofetil",
      "effect": "↓ mycophenolate",
      "suggestion": "Monitor, avoid if possible"
    },
    {
      "drug": "Nilotinib",
      "effect": "Altered absorption of nilotinib",
      "suggestion": "See PI of nilotinib"
    },
    {
      "drug": "Oral contraceptives",
      "effect": "↓ ethinyl estradiol, ↓ norethindrone",
      "suggestion": "Use alternative method"
    },
    {
      "drug": "Phenytoin",
      "effect": "↑ phenytoin",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Posaconazole",
      "effect": "↑ omeprazole, ↑ rifabutin",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Probenecid",
      "effect": "↑ amoxicillin",
      "suggestion": "Monitor"
    },
    {
      "drug": "Rifampin",
      "effect": "↓ omeprazole, ↓ rifabutin",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Rilpivirine",
      "effect": "↓ rilpivirine",
      "suggestion": "Contraindicated"
    },
    {
      "drug": "St. John's wort",
      "effect": "↓ omeprazole, ↓ rifabutin",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Tacrolimus",
      "effect": "↑ tacrolimus",
      "suggestion": "Monitor, adjust dosage"
    },
    {
      "drug": "Voriconazole",
      "effect": "↑ omeprazole, ↑ rifabutin",
      "suggestion": "Contraindicated"
    },
    {
      "drug": "Warfarin",
      "effect": "↑ INR",
      "suggestion": "Monitor INR, adjust dosage"
    }
  ],
  "comments": [
    "Review: Med Lett Drugs Ther 2020;62:83."
  ]
}
